Featured Articles

Ensuring the purity and safety of pharmaceutical products is a critical aspect of drug development and manufacturing. Impurities in drugs, whether from synthesis, degradation, or contamination, can have profound implications for patient health. Mass ... Read More

The new Lenti RapidTiter™ Sticks by Origene offer a fast, efficient, and semi-quantitative method for monitoring lentiviral titers. By detecting the P24 protein in both cell cultures and purified samples, users can quickly assess their lentiviral ... Read More

This article provides a brief summary of FDA’s previous enforcement approach and a high-level overview of the phase-out policy as provided in the draft guidance. Read More

As new therapies for often hard-to-treat diseases, such as cancer or rare diseases, are discovered and developed, biopharma companies must continue to adopt technologies that allow them to rapidly commercialize their pipelines and accelerate time to ... Read More

While a productivity crisis in the pharmaceutical industry still exists, we have seen some promising improvement thanks to innovations in technology, the use of human-relevant disease models, combined with ‘omics technologies and advanced imaging ... Read More

For the production of high-quality CGT products, it is essential to accurately assess cell growth and differentiation, and create an optimal cell culture environment. Read More